CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 135,115	$ 246,487	[1]
Related party receivables from collaborative arrangements	101,271	93,931	[1]
Prepaid expenses and other current assets	542	1,640	[1]
Total current assets	236,928	342,058	[1]
Property and equipment, net	15	28	[1]
Equity and long-term investments	507,116	438,258	[1]
Capitalized fees paid to a related party, net	114,885	125,253	[1]
Deferred tax assets, net	28,159	93,759	[1]
Other assets	136	214	[1]
Total assets	887,239	999,570	[1]
Current liabilities:
Accounts payable	89	66	[1]
Accrued personnel-related expenses	488	490	[1]
Accrued interest payable	1,668	4,152	[1]
Other accrued liabilities	880	1,402	[1]
Total current liabilities	3,125	6,110	[1]
Long-term debt, net of discount and issuance costs	392,295	385,517	[1]
Other long-term liabilities	14	106	[1]
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding	0	0	[1]
Common stock: $0.01 par value, 200,000 shares authorized, 69,492 and 101,392 issued and outstanding as of September 30, 2021 and December 31, 2020 respectively	695	1,014	[1]
Treasury stock: at cost, 32,005 and no shares at September 30, 2021 and December 31, 2020, respectively	(393,829)	0	[1]
Additional paid-in capital	1,262,438	1,260,900	[1]
Accumulated deficit	(466,493)	(722,002)	[1]
Total Innoviva stockholders' equity	402,811	539,912	[1]
Noncontrolling interest	88,994	67,925	[1]
Total stockholders' equity	491,805	607,837	[1]
Total liabilities and stockholders' equity	$ 887,239	$ 999,570	[1]

[1] Consolidated balance sheet as of December 31, 2020 has been derived from audited consolidated financial statements.